- Home
- GRFS vs BIRK Comparison
GRFS vs BIRK Comparison
Compare GRFS & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRFS | BIRK |
|---|---|---|
| Founded | 1940 | 1774 |
| Country | Spain | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.6B |
| IPO Year | 2008 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GRFS | BIRK |
|---|---|---|
| Price | $7.36 | $30.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | $10.15 | ★ $61.43 |
| AVG Volume (30 Days) | 371.0K | ★ 2.4M |
| Earning Date | 07-28-2022 | 05-13-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | $13.71 |
| Revenue Next Year | $6.42 | $14.30 |
| P/E Ratio | $18.67 | ★ $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.96 | $30.25 |
| 52 Week High | $10.23 | $50.73 |
Technical Indicators
Market Signals| Indicator | GRFS | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 28.97 |
| Support Level | $7.33 | N/A |
| Resistance Level | $8.36 | $37.29 |
| Average True Range (ATR) | 0.14 | 1.18 |
| MACD | -0.05 | -0.24 |
| Stochastic Oscillator | 3.17 | 6.08 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.